This report is a pilot study to determine the clinical effects of post-partum plasma in rheumatoid arthritis. After 1 2 years of unsuccessful efforts to collect post-partum plasma through our obstetrical service on a voluntary basis, a grant of funds from the New York Chapter of the Arthritis and Rheumatism Foundation has made it possible to persuade donors to offer the necessary plasma.
Our observations are derived from a series of eleven patients with active rheumatoid arthritis who were given transfusions of post-partum plasma.
Material
The selection of cases for this report was based on the diagnostic criteria for active rheumatoid arthritis established by the American Rheumatism Association in the "Primer and Handbook for Arthritis Clinics" (Steinbrocker and others, 1949) .
The ages of our eleven patients ranged from 29 to 59 years. There were seven females and four males. The average duration of the disease was 4-8 years, varying from 6 months to 15 years. All the patients selected for treatment had previously received physiotherapy and salicylates; five had previously been given Butazolidin, two chrysotherapy, two F alcohol, and three cortisone. Only one of the patients previously given steroid therapy had received any within 3 months of starting plasma.
Methods
The technique described by Granirer (1952) was followed meticulously. The only modification was the use of type-specific plasma, rather than pooled plasma, to obviate the possibility of reactions (Angrist, 1952; Hsia and others, 1953) . Cross-matching was performed before each transfusion as an added precautionary measure.
Venous blood was obtained 12-48 hrs post-partum. All of the post-partum donors were on the obstetrical service of the Lenox Hill Hospital. When indicated, the red cells were returned intravenously to the donor.
The plasma was prepared in our blood bank in the routine manner. For precautionary measures it was deemed necessary to obtain two sterile cultures at 14-day intervals before the plasma was used.
Each patient was observed for a minimum period of 3 weeks, either in the hospital or in the out-patient clinic, before the initiation of our therapy.
The plasma was administered intravenously in doses of 250-275 ml. at weekly intervals for an arbitrarily selected course of 10 weeks.
To determine the clinical effects, a weekly appraisal of each patient was performed by two observers. Evaluation of each patient's progress included the routine assessment of four subjective factors:
(1) pain, (2) stiffness, (3) sense of well-being, (4) joint tenderness.
Objective evaluation was based on the therapeutic criteria of the American Rheumatism Association (Steinbrocker and others, 1949) . Radiographs of the affected joints were repeated when indicated. Temperature, pulse, and weight were recorded routinely.
Certain laboratory studies on each patient were repeated at bi-weekly intervals:
(1) Complete blood count and haemoglobin, (2) Erythrocyte sedimentation rate, (3) Total cholesterol and partition, (4) Total serum proteins, albumin-globulin ratio, and circulating eosinophil counts.
Rose tests (SCA) were performed both before and after treatment. 131
Results
No consistent subjective or objective improvement was noted in any of these patients. Table I gives a summary of our results, including the number of transfusions of post-partum plasma, the stage of the disease, the sedimentation rate before and after therapy, the functional class before and after treatment, and the grade of response.
Eight patients completed the arbitrary course of ten transfusions. One patient obtained moderate subjective and objective benefit after the seventh treatment, but gradually worsened in spite of continuing therapy and an additional transfusion. After the eleventh post-partum plasma, plain blood plasma was introduced for 2 weeks without the patient's knowledge. Her condition continued to deteriorate, and she was started on oral Compound F alcohol and a moderate response soon followed.
In three patients, plasma therapy had to be discontinued after eight and nine transfusions, respectively, because of marked progression of the disease.
Two patients obtained some questionable subjective improvement that was not sustained. (Scudder, 1953) . These were of three types:
(1) urticaria, (2) rises in temperature, (3) chills or chilly sensations with or without a rise in temperature.
Reactions usually developed soon after the transfusions; they were easily controlled by the usual measures, and in the cases of urticaria by antihistaminics. No instance of homologous serum jaundice has occurred so far, but many of the patients were not out of the potential incubation period at the time of writing.
Controls.-The complete lack of response to the post-partum plasma nullified the need for administering the control plasmas which were originally planned as part of the study.
Discussion
The observation that patients with active rheumatoid arthritis may experience a remission or show decided improvement during pregnancy has been confirmed by many investigators (Alfred-Brown, 1942; Sclater, 1943; Flynn, 1942; Hench, 1938; Holbrook, 1948) . Hench (1938) (1) Direct influence of pregnancy,
(2) Indirect effect through products of pregnancy.
Direct Effect.-Pregnancy per se has been advised by some as a therapeutic aid (Holbrook, 1948) , but needless to say this is not always practicable.
An attempt at producing a state of "pseudopregnancy" with massive doses of human chorionic hormone in a patient with rheumatoid arthritis was reported by Archer (1950) , but pseudo-pregnancy was not achieved and no clinical benefit resulted.
We were unable to uncover any report in the literature describing the effect upon rheumatoid arthritis in patients developing pseudo-cyesis.
Indirect Effect.-The indirect effect through pregnancy-products is the more practical and is the one with which we are chiefly concerned. The current interest in the use of pregnancy blood and its derivatives was initiated by Barsi in 1941; 6 years later (Barsi, 1947) he reported a study of 28 patients and described beneficial results in 64 per cent., with no change in 36 per cent. of his series. He felt the results were not statistically significant, but was impressed with the rapidity of improvement and the lasting effects in those patients favourably affected.
Since that time other workers have reported the use of pregnancy blood, post-partum plasma, and placental cord serum. eight patients treated with injections of placental serum, in whom no significant beneficial effect was obtained. Granirer (1951) reported the successful use of post-partum plasma in eight patients with rheumatoid arthritis. In this study he stated that all his patients sustained gradual remissions lasting from 6 weeks to Ij years. Chemical abnormalities of the blood, such as anaemia and reversal of the albumin/ globulin ratio, were restored to normal. However, the blood sedimentation rate did not improve. No beneficial response was obtained when plain plasma was administered to a control group of patients.
Norcross and Lockie (1951) administered 250 ml. post-partum plasma once a week for a period of 12 weeks to six patients with active rheumatoid arthritis. No subjective or objective improvement was obtained. Bunim (1951) mentioned two patients who failed to respond to sixteen post-partum transfusions, but showed moderate improvement when a steroid compound was administered. Hsia and others (1953) recently reported the administration of Cohn's Fraction IV prepared from pooled post-partum plasma to a total of sixteen children, seven with rheumatoid arthritis. No beneficial effect on the rheumatoid arthritis was observed, and four out of the sixteen patients treated developed homologous serum hepatitis.
Although our series consists of only eleven patients, for the purposes of a screening study of the effects of post-partum plasma, we feel this material is adequate to reflect at least the trend of responsiveness, since the original report on this subject was based on only eight cases, and no further analysis of results in a larger group has appeared to our knowledge. Moreover, it has been stated by Granirer that improvement usually occurs between the fourth and sixth treatment, and all but one of the patients in this series have received eight or more transfusions of the specific plasma.
Plain Blood and Plasma Transfusions.-Some investigation of the use of normal blood and plasma in the treatment of rheumatoid arthritis has also been pursued. Repeated transfusions of normal blood have been recommended in patients with relatively acute or subacute rheumatoid arthritis. After the transfusions some striking remissions of the disease have been described by some observers (Holbrook, 1951) . Simpson and others (1949) treated forty patients with rheumatoid arthritis with blood transfusions, and ten patients with plasma transfusions. An immediate improvement in levels of haemoglobin, haematocrit, and blood sedimentation rate occurred in all patients given whole blood. However, these constituents returned to their previous abnormal values within 28 days. Patients given plasma showed no improvement in these estimations. The arthritis was reported to be unaffected by the transfusions. Summary (1) The clinical and certain haematological and biochemical effects produced by the intravenous administration of 250 ml. post-partum plasma once a week for 8 weeks were observed in a series of eleven patients with active rheumatoid arthritis.
(2) This study has failed to demonstrate any significant responsive trend or any appreciable beneficial effect of post-partum plasma on the symptoms or course of active rheumatoid arthritis.
(3) No significant influence on abnormal blood chemical constituents was observed in any of our group during or after the administration of postpartum plasma.
(4) The administration of post-partum plasma as a therapeutic measure for rheumatoid arthritis in our small series demonstrated no evidence of benefit to justify its further investigation.
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Effet du plasma puerperal sur l'arthrite rhumatismale R1SUME
(1) On observa les effets cliniques et certains effets hematologiques et biochimiques produits par l'administration intraveineuse de 250 cc. de plasma puerperal une fois par semaine a un groupe de onze malades atteints d'arthrite rhumatismale.
(2) Au cours de cette experience on ne put deceler aucune tendance 'a une reponse significative ni aucun effet salutaire appreciable du plasma puerperal sur les sympt6mes ou l'evolution de l'arthrite rhumatismale active.
(3) Pendant ou apres l'administration du plasma puerperal on n'observa dans aucun cas un effet significatif sur les composants chimiques anormaux du sang.
(4) Dans notre petite serie l'administration a titre therapeutique du plasma puerperal dans l'arthrite rhumatismale n'offrit aucune indication favorable qui puisse justifier des recherches ulterieures.
Efecto del plasma puerperal sobre la artritis reumatoide SUMARIO
(1) Se observ6 los efectos clinicos y algunos efectos hematol6gicos y bioquimicos consecuentes a la administracion endovenosa de 250 cc. de plasma puerperal una vez por semana a un grupo de once enfermos con artritis reumatoide.
(2) No fue posible demostrar en este estudio tendencia alguna a una respuesta significativa ni efecto beneficioso apreciable del plasma puerperal sobre los sintomas o la evoluci6n de la artritis reumatoide activa.
(3) Durante o despues de la administraci6n del plasma puerperal en ningu6n caso se vi6 un efecto significativo sobre los componentes quimicos anormales de la sangre.
(4) En nuestra pequefia serie la administraci6n de plasma puerperal como medida terapeutica en la artritis reumatoide no evidencio ventaja alguna que pudiera justificar investigaciones ulteriores.
